Advice
Medicine discontinued
On 31 March, 2024, exenatide (Byetta®), 5 micrograms & 10 micrograms, solution for injection, prefilled pen was discontinued.
Medicine details
- Medicine name:
- exenatide (Byetta)
- SMC ID:
- 684/11
- Indication:
for the treatment of type 2 diabetes mellitus in combination with metformin + TZD.
- Pharmaceutical company
- Eli Lilly and Company Ltd
- BNF chapter
- Endocrine system
- Submission type
- Full
- Status
- Withdrawn
- Date advice published
- 07 March 2011
Additional notes
On 31 March, 2024, exenatide (Byetta®), 5 micrograms & 10 micrograms, solution for injection, prefilled pen was discontinued.